Outcomes of Treatment Using the ERMI Shoulder Flexionater ®
Outcomes of Treatment Using the ERMI Shoulder Flexionater®
Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.
Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.
Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study 1 - Adhesive Capsulitis Study (AC)
Objective: The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
- Prospective randomized control trial
- Sample size - 110 patients
Study Groups:
- Group I - Physical Therapy Only
- Group II - Flexionater® only
- Group III - Flexionater® and Physical Therapy
- Length of study - 2-year follow-up from last enrolled patient
Study 2 - Postoperative Shoulder Stiffness Study (POS)
Objective: The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.
- Prospective randomized control trial
- Sample size - 90 enrolled patients
Study Groups:
- Group I - Physical Therapy only
- Group II - Flexionater® only
- Group III - Flexionater® and Physical Therapy
- Length of study - 2-year follow-up from last enrolled patient
Study 3 - Secondary Surgery Study (SAM)
Objective: The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
- Prospective randomized control trial
- Sample size - 10 enrolled patients
Study Groups:
- Group I Physical Therapy Only
- Group II - - Flexionater® only
- Group III - Flexionater® and Physical Therapy
- Length of study - 2-year follow-up from last enrolled patient
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Deborah H Warren, RN
- Phone Number: 6766 8139789700
- Email: dwarren@foreonline.org
Study Contact Backup
- Name: Viki Sochor
- Phone Number: 6832 813-978-9700
- Email: vsochor@foreonline.org
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33607
- Foundation for Orthopaedic Research and Education
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
For Study Group 1- Adhesive Capsulitis (AC)
Inclusion Criteria:
- Exhibits symptoms of adhesive capsulitis i. Shoulder pain with limited motion for more than one month ii. AND ≤ 30 degrees external rotation with arm at side iii. AND ≤ 130 degrees forward flexion d. Cortisone shot for all patients
Exclusion Criteria:
- a. No prior shoulder surgery b. Infection c. Rheumatoid arthritis d. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder
For Study Group 2 - Postoperative Shoulder Stiffness Study (POS)
Inclusion Criteria:
c. Is not recovering normally based on objective criteria set for screening process i. Step 1 - Follow patients -all post-op patients with indicated procedures (see # 7 for list.) ii. Step 2 - Screen Patients -does patient meets inclusion criteria at 6 weeks or 3 months of follow-up?
- < 15 degrees external rotation with arm at side at 6 weeks post-op
- OR < 90 degrees forward flexion at 3 months post-op iii. Step 3 - Enroll patients that meet inclusion criteria and assign group
Exclusion Criteria:
a. Revision surgery b. Infection c. Rheumatoid arthritis
7. Procedures included
- Shoulder arthroscopic procedures (29827, 29828, 29823,29824, 29826)
ORIF Humerus fracture (23615)
For Study Group 3, Secondary Surgery Study (SAM)
Inclusion Criteria:
- Underwent a manipulation under anesthesia or a lysis of adhesions procedure
Exclusion Criteria:
a. Infection b. Rheumatoid arthritis c. Any structural or systemic disorder that could result in pain or ROM limitation i. Such as inflammatory joint disease, osteoarthritis evidenced on radiographs ii. full thickness rotator cuff tear as shown by ultrasound imaging iii. history of major trauma or surgery involving the shoulder
7. Procedures included
- Manipulation under anesthesia (23700)
- Lysis of adhesions (29825)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Adhesive Capsulitis Study
The purpose of this study is to compare treatment efficacy of patients with symptoms of primary and secondary adhesive capsulitis between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
|
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Other Names:
|
|
Active Comparator: Post operative Shoulder Stiffness Study
The purpose of this study is to compare treatment efficacy of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Patients treated with Physical Therapy alone; II) Patients treated with the ERMI Shoulder Flexionater® alone; III) Patients treated with PT + Device in the treatment.
|
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Other Names:
|
|
Active Comparator: Secondary Surgery Study
The purpose of this study is to compare recovery of patients who have undergone a manipulation under anesthesia or a lysis of adhesions between three groups: 1) Patients treated with Physical Therapy alone; 2) Patients treated with the ERMI Shoulder Flexionater® alone; 3) Patients treated with PT + Device in the treatment.
|
High Intensity Stretch and Physical Therapy are used either together or alone to treat study arm.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Shoulder Range of Motion Improvement
Time Frame: 3 months
|
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
|
3 months
|
|
Shoulder Range of Motion
Time Frame: 6 months
|
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
|
6 months
|
|
Shoulder Range of Motion
Time Frame: 12 months
|
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
|
12 months
|
|
Shoulder Range of Motion
Time Frame: 24 months
|
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
|
24 months
|
|
Shoulder Range of Motion
Time Frame: 6 weeks
|
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
|
6 weeks
|
|
Shoulder Range of Motion
Time Frame: baseline
|
Measuring Shoulder External Rotation and Forward Flexion using a goniometer according to standard practice
|
baseline
|
|
VAS (Visual Analog Scale) Pain Score
Time Frame: 3 months
|
Visual Analog Scale Pain Score 0 (no pain) - 10 (pain as bad as it can be)
|
3 months
|
|
VAS Pain Score
Time Frame: 6 weeks
|
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
|
6 weeks
|
|
VAS Pain Score
Time Frame: 6 months
|
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
|
6 months
|
|
VAS Pain Score
Time Frame: 12 months
|
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
|
12 months
|
|
VAS Pain Score
Time Frame: 24 months
|
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
|
24 months
|
|
VAS Pain Score
Time Frame: baseline
|
Visual Analog Scale Pain Score: 0 (no pain) - 10 (pain as bad as it can be)
|
baseline
|
|
ASES Score
Time Frame: baseline
|
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
|
baseline
|
|
ASES Score
Time Frame: 3 month
|
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
|
3 month
|
|
ASES Score
Time Frame: 6 weeks
|
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
|
6 weeks
|
|
ASES Score
Time Frame: 6 months
|
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
|
6 months
|
|
ASES Score
Time Frame: 12 months
|
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
|
12 months
|
|
ASES Score
Time Frame: 24 months
|
American Shoulder and Elbow Society Score (10 activities of daily living are calculated)
|
24 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SST
Time Frame: Baseline
|
Simple Shoulder Test
|
Baseline
|
|
SST
Time Frame: 3 month
|
Simple Shoulder Test
|
3 month
|
|
SST
Time Frame: 6 weeks
|
Simple Shoulder Test
|
6 weeks
|
|
SST
Time Frame: 6 months
|
Simple Shoulder Test
|
6 months
|
|
SST
Time Frame: 12 months
|
Simple Shoulder Test
|
12 months
|
|
SST
Time Frame: 24 months
|
Simple Shoulder Test
|
24 months
|
|
Device Compliance Questionnaire (if applicable)
Time Frame: 6 weeks
|
compliance with Device usage
|
6 weeks
|
|
Device Compliance Questionnaire (if applicable)
Time Frame: 3 months
|
compliance with Device usage
|
3 months
|
|
Device Compliance Questionnaire (if applicable)
Time Frame: 6 months
|
compliance with Device usage
|
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Peter Simon, PhD, Foundation for Orthopaedic Research and Education
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FORE AC 2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.